Prelude Capital Management’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83K | Buy |
+56,055
| New | +$83K | 0.01% | 927 |
|
|
2017
Q3 | – | Sell |
-200
| Closed | -$2K | – | 1711 |
|
|
2017
Q2 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 1406 |
|
|
2017
Q1 | – | Sell |
-1,050
| Closed | -$5K | – | 1661 |
|
|
2016
Q4 | $5K | Buy |
+1,050
| New | +$5K | ﹤0.01% | 1389 |
|
|
2016
Q3 | – | Sell |
-10
| Closed | – | – | 1685 |
|
|
2016
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 1629 |
|